B-Cell Non-Hodgkin Lymphoma
Showing NaN - NaN of 1
B-cell Non-Hodgkin Lymphoma Trial in Worldwide (Mosunetuzumab (IV), Mosunetuzumab (SC), Polatuzumab vedotin)
Recruiting
- B-cell Non-Hodgkin Lymphoma
- Mosunetuzumab (IV)
- +4 more
-
Birmingham, Alabama
- +28 more
Jan 6, 2023